Investigators identified Myosin Heavy Chain 6 (MYH6) as a potential tumor suppressor gene in the development of prostate cancer. They found lower expression of MYH6 in prostate cancer tissues, and its lower gene expression was also associated with worse clinical outcomes.
[Scientific Reports]
